Answers are grounded in this paper and cite their sources.
Due to the global increase in diabetes, diabetic nephropathy is becoming a significant issue. Diagnosis and treatment in the early stages of nephropathy may avert this considerable complication, and new biomarkers other than microalbuminuria are required to detect diabetic nephropathy earlier in type 2 diabetes mellitus. Moreover, the pathogenesis of complications associated with diabetes as indicated in recent experimental studies showed that growth arrest-specific-6 protein (Gas-6) might have a role. We therefore, embarked on this study to determine the pattern of plasma Gas-6 elevation among type 2 diabetes mellitus patients and to describe any relationship with microalbuminuria using urinary albumin creatinine ratio. This research was a descriptive; a hospital-based cross-sectional study conducted at the Endocrinology Clinic, University College Hospital, Ibadan, Oyo State, Nigeria. We recruited 71 type-2 diabetic participants, and 71 apparently-healthy participants who served as the control. The study showed that the concentrations of Gas-6 protein and UACR in the diabetic participants were all significantly higher than in the healthy control participants (p ˂ 0.001). There was also a positive correlation between Gas-6 protein and UACR value which was statistically significant (rho = 0.41, p = ˂0.001). The sensitivity and specificity of Gas-6 was 75.0% and 19.1% respectively, with a PPV and NPV of 0.68 and 0.25 respectively. In conclusion, Plasma Gas-6protein correlated with microalbuminuria. However, Gas-6 protein alone may be of limited diagnostic value in diabetic nephropathy.
No takes yet. Share an insight, caveat, or question.
Emedoh et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: